The project, led by Prof. Eran Segal and his team in the Department of Computer Science and Applied Mathematics and Department of Molecular Cell Biology, aims to use state-of-the-art artificial intelligence technologies to generate personalized predictions for disease risk factors. The 10K project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals who will be recruited from the Israeli population, and is suitable for Hebrew speakers only.
April 08, 2019
The Weizmann Institute’s Prof. Dan Yakir has won this year’s Israel Prize for Research in Geology, Earth Sciences and Atmospheric Sciences, for his groundbreaking insights into the impact of semi-arid forests on the global climate. “At the station he founded in the Yatir Forest, Prof. Yakir explores the interactions between the biosphere and the atmosphere, especially the ways in which vegetation influences the environment and the climate,” Education Minister Naftali Bennett tweeted.
April 02, 2019
Imagine the ability to prevent all strains of the flu for many years—in a single shot. In the third episode of Weizmann in Focus, CEO Dave Doneson spotlights Prof. Ruth Arnon’s remarkable progress on a universal flu vaccine. The vaccine, being brought to market by Israeli startup Biondvax, holds the promise of protecting us from current and future varieties of the virus.
Click below to watch—and please share the video with friends via email or social media.
Israel’s lunar lander – which Weizmann has been helping develop – is en route to the Moon. The XPRIZE Foundation, “inspired” by the effort, has announced creation of a new “Moonshot Award,” which the SpaceIL team will receive upon a successful landing.
March 28, 2019
Our gut microbiome – the complement of bacteria we carry around in our intestines – has been linked to everything from obesity and diabetes to heart disease and even neurological disorders and cancer. In recent years, researchers have been sorting through the multiple bacterial species that populate the microbiome, asking which of them can be implicated in specific disorders. But a paper recently published in Nature addressed a new question: “What if the same microbe is different in different people?”
March 27, 2019
Israel21C reports on 10 major Israeli research projects focused on circadian rhythm. Four projects are by Weizmann scientists: two by Prof. Gad Asher, one by Prof. Tsvee Lapidot, and one by Prof. Eran Segal.
March 25, 2019
The Jerusalem Post reports on a company established by a Weizmann Institute alum, Nir Erez, who left a job in big pharma to find a way to help cancer sufferers. His firm, Trial-In Pharma, connects patients to 20,000 clinical trials and compassionate use treatments worldwide.
March 24, 2019
On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics.
March 22, 2019
The Midwest Region’s annual Gala Dinner took place at The Geraghty in Chicago with over 600 guests in attendance. Local civic and community leaders came together to honor Michael Polsky, Founder and CEO of Invenergy. A dedicated philanthropist and energy industry pioneer, Mr. Polsky received the Weizmann Leadership Award. The evening’s program, emceed by ABC 7 reporter Janet Davies, also consisted of presentations by University of Chicago President Robert Zimmer and Prof. Avigdor Scherz, Department of Plant and Environmental Sciences, who discussed his cutting-edge cancer research. Chaired by Janet and Steven Anixter and JoAnn Anixter Silva, the highly successful gala raised over $1.3 million in support of the Weizmann Institute.
©2019 American Committee for the Weizmann Institute of Science
